At close: December 11 at 11:24:44 AM EST
Breakdown
TTM
1/31/2024
1/31/2023
1/31/2022
1/31/2021
Operating Cash Flow
-2,511.5380
-2,472.4100
-1,503.5120
-11,202.8200
-7,164.8810
Investing Cash Flow
--
--
--
--
-71.5500
Financing Cash Flow
2,576.8400
2,501.5430
1,335.8890
11,233.5210
4,089.6440
End Cash Position
126.2940
37.3840
8.3070
173.5130
154.7220
Interest Paid Supplemental Data
--
--
--
--
480.6360
Capital Expenditure
--
--
--
--
-96.6150
Issuance of Capital Stock
1,092.4000
2,201.5430
833.3130
11,440.7050
1,289.3430
Issuance of Debt
1,524.2000
300.0000
--
120.0000
--
Repayment of Debt
--
--
--
-250.0000
-499.9290
Free Cash Flow
-2,511.5380
-2,472.4100
-1,503.5120
-11,202.8200
-7,261.4960
1/31/2021 - 12/19/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
PTIXW Protagenic Therapeutics, Inc.
0.0140
+60.92%
RNV.AX RENERVE FPO [RNV]
0.1450
-14.71%
NRXBF NUREXONE BIOLOGIC INC
0.5397
0.00%
AGNPF Algernon Pharmaceuticals Inc.
0.0460
0.00%
VXLLF Vaxil Bio Ltd.
0.0080
0.00%
AGN.CN Algernon Pharmaceuticals Inc.
0.0650
-7.14%
AWKN.CN AwaknLifeSc
0.0950
0.00%
BIXT Bioxytran, Inc.
0.0890
+0.45%
RCE.AX Recce Pharmaceuticals Ltd
0.4750
-6.86%
BVAXF BioVaxys Technology Corp.
0.0435
+9.30%